European Genomics and Epigenomics - Translating Genomic and epigenetic Studies of MDS and AML (EuGESMA)

Grunddaten zu diesem Projekt

Art des ProjektesEU-Projekt koordiniert außerhalb der Universität Münster
Laufzeit an der Universität Münster01.01.2009 - 30.11.2012

Beschreibung

Active research across Europe concentrates into identifying the molecular mechanisms and mutations in AML (acute myeloid leukaemia) and MDS (myelodysplastic syndrome), utilizing high level technologies such as mRNA or miRNA expression profiling, genome-wide epigenetic or genotyping. The aim is to understand the molecular basis of these diseases, to develop technologies for improving diagnosis, prognosis and move towards personalised therapeutic choices. This Action will establish a wider European network to promote contacts and exchanges of experience and technology among laboratories involved in basic research and diagnostic services and promote the development of new resources and technological tools providing new insights into basic pathogenesis and improve clinical investigations. The European Genomic and Epigenetic Study on MDS and AML (EuGESMA) COST Action would establish a permanent network among outstanding groups who actively contribute to the understanding and integration of modern genomics technologies with the aim of translating these into a clinical environment.

StichwörterExpertennetzwerk
FörderkennzeichenBM0801
Mittelgeber / Förderformat
  • EU - COST Actions (COST)

Projektleitung der Universität Münster

Dugas, Martin
Institut für Medizinische Informatik

Antragsteller*innen der Universität Münster

Dugas, Martin
Institut für Medizinische Informatik

Koordinierende Organisationen außerhalb der Universität Münster

  • Queen's University Belfast (QUB)Vereinigtes Königreich